Two Cases of Hepatitis B Virus-associated Membranoproliferative Glomerulonephritis with Contrasting Renal and Survival Outcomes after Antiviral Therapy

We examined renal biopsy specimens from two men (ages 36 and 35 years) who had been diagnosed with chronic hepatitis or cirrhosis, were positive for hepatitis B virus (HBV)-e antigen and proteinuria, and diagnosed with HBV-associated membranoproliferative glomerulonephritis. Antiviral medications for HBV were effective in one patient who was negative for HBV-e antigen, and his proteinuria improved. However, in the other patient, only limited therapeutic efficacy was observed and nephropathy progressed, necessitating dialysis. The patient developed hepatocellular carcinoma and died. The efficacy of antiviral therapy for HBV was associated with renal and survival outcomes.

Authors

Institutions

Publication Details

Journal
Internal Medicine
Published
2025-11-12
DOI
https://doi.org/10.2169/internalmedicine.6218-25
Primary Topic
Hepatitis B Virus Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Two Cases of Hepatitis B Virus-associated Membranoproliferative Glomerulonephritis with Contrasting Renal and Survival Outcomes after Antiviral Therapy

Yoshifumi Ubara, Naoki Sawa, Takeshi Fujii, Hiroki Mizuno et al.
Internal Medicine
Hepatitis B Virus Studies
article

Two Cases of Hepatitis B Virus-associated Membranoproliferative Glomerulonephritis with Contrasting Renal and Survival Outcomes after Antiviral Therapy

Yoshifumi Ubara, Naoki Sawa, Takeshi Fujii, Hiroki Mizuno, Kei Kono, Yutaka Takazawa, Yuki Oba, Takehiko Wada, Noriko Inoue, Akinari Sekine, Eiko Hasegawa, Satoshi Saitoh, Kiho Tanaka, Kenichi Ohashi, Masayuki Yamanouchi, Tatsuya Suwabe
article en

Abstract

We examined renal biopsy specimens from two men (ages 36 and 35 years) who had been diagnosed with chronic hepatitis or cirrhosis, were positive for hepatitis B virus (HBV)-e antigen and proteinuria, and diagnosed with HBV-associated membranoproliferative glomerulonephritis. Antiviral medications for HBV were effective in one patient who was negative for HBV-e antigen, and his proteinuria improved. However, in the other patient, only limited therapeutic efficacy was observed and nephropathy progressed, necessitating dialysis. The patient developed hepatocellular carcinoma and died. The efficacy of antiviral therapy for HBV was associated with renal and survival outcomes.

Internal Medicine
Institute of Human Sciences (AT), Toranomon Hospital (JP)
Openalex Percentile: Top 55%
Hepatitis B Virus Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.